Phthalates and Bisphenol A: presence in blood serum and follicular fluid of italian women undergoing assisted reproduction techniques

Background: folliculogenesis is a strictly regulated process that may be affected by endocrine disrupting chemicals (EDCs) through sometimes not so clear molecular mechanisms. Methods: we conducted a multicentric observational study involving six fertility centers across Italy, prospectively recruiting 122 women attending a fertility treatment. Recruited women had age ≤42 years, and normal ovarian reserve. Blood and follicular fluid samples were taken for EDCs measurement using liquid chromatography tandem mass spectrometry and each woman completed an epidemiological questionnaire. Results: The main EDCs found were monobutyl phthalate (MBP) (median blood: 8.96 ng/mL, follicular fluid 6.43 ng/mL), monoethylhexyl phthalate (MEHP) (median blood: 9.16 ng/mL, follicular fluid 7.68 ng/mL) and bisphenol A (BPA) (median blood: 1.89 ng/mL, follicular fluid 1.86 ng/mL). We found that serum MBP concentration was significantly associated with the considered area (p < 0.001, adj. mean: 7.61 ng/mL, 14.40 ng/mL, 13.56 ng/mL; Area 1: Milan–Turin, Area 2: Rome–Naples; Area 3: Catania–Bari, respectively) but negatively with home plastic food packaging (p = 0.004). Follicular MBP was associated with irregular cycles (p = 0.019). No association was detected between EDCs and eating habits and other clinical and epidemiological features. Conclusions: This study represents the first Italian biomonitoring of plastic EDCs in follicular fluid, laying the basis for future prospective evaluation on oocyte quality before assisted reproduction techniques (ART

Seasonality and human in vitro fertilization outcome

Seasonal changes in spontaneous fecundity have been observed in several human populations, but it is not clear whether the same applies to human in vitro fertilization-embryo transfer (IVF) procedures. In the present study, 2067 patients undergoing their first IVF attempt between the years 1998 and 2003 were grouped into four 'seasons' (December-February, March-May, June-August, September-November) according to the day on which they were administered human chorionic gonadotropin. Several parameters known to affect IVF outcome (including ovarian response to gonadotropins, sperm and oocyte quality, fertilization rate, embryo quality, pregnancy and implantation rates) were considered and potential changes among the four seasonal periods were analyzed. Moreover, some confounding variables (sperm quality, age, duration of infertility, indications for IVF) were controlled for. Overall, pregnancy rate per oocyte pick-up and per embryo transfer of 32.5% and 35.8%, respectively, as well as implantation rate of 18.9%, were recorded. None of the observed IVF-related parameters showed any significant change clearly related to a specific seasonal period, their fluctuations throughout the year being randomly determined. Ovarian responsiveness to gonadotropins, quality of gametes and embryos, and fertilization and implantation processes were apparently not significantly affected by seasonality. It is concluded that the results of a good-quality IVF program in humans are not significantly affected by the season of the year in which the IVF attempt is accomplished; therefore, season is not a relevant factor to be considered when planning an IVF treatment. © 2005 Taylor & Francis Group Ltd

Hirschsprung's disease and Down syndrome: From the reappraisal of risk factors to the impact of surgery

Introduction: The association of Hirschsprung disease (HSCR) and Down Syndrome (DS) is not uncommon (HSCR + DS). This paper aims at reporting the results of a 24-year series focusing on surgical approach, complications and long term outcome. Materials and methods: The notes of all patients admitted with a diagnosis of HSCR + DS have been retrospectively reviewed. Surgical details, intraoperative complications, long term issues and functional outcome have been recorded. The results have been compared to those of patients without DS and were assessed based on surgical approach. Results: A total of 23 HSCR + DS out of a series of 385 HSCR (6%) have been included. Preoperative enterocolitis (HAEC) was reported by 32%. Associated anomalies were detected in more than half of the patients. In particular, Congenital Heart Defects (CHDs) were reported by 57%. Postoperative complications (mostly symptomatic anal sphincter achalasia) were experienced by 55%. Constipation was experienced by 30%; severe continence issues, by 53%. One patient suffering from severe CHDs died. With regard to complications, only symptomatic anal achalasia requiring intrasphincteric BoTox injection was significantly more frequent in HSCR + DS (30% vs 10%, p = 0.0071). Similarly, continence proved to be significantly worse in HSCR + DS. Discussion: With the exception of symptomatic anal achalasia, HSCR + DS patients proved not to have a higher likelihood of complications compared to HSCR alone. On the other hand, functional results in the long term are worse. As a consequence, long term follow up and personalized rehabilitation programs are warranted for this delicate subset of HSCR patients. Level of evidence: Level III

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation A Report From the GARFIELD-AF Registry

IMPORTANCE Congestive heart failure (CHF) is commonly associated with nonvalvular atrial fibrillation (AF), and their combination may affect treatment strategies and outcomes